Resultados de procura - Pedram Razavi
- Mostrando 1 - 20 Resultados de 57
- Go to Next Page
-
1
-
2
Next-generation selective estrogen receptor degraders and other novel endocrine therapies for management of metastatic hormone receptor-positive breast cancer: current and emerging... por Maxwell R. Lloyd, Seth A. Wander, Erika Hamilton, Pedram Razavi, Aditya Bardia
Publicado 2022Revisão -
3
-
4
-
5
Clinical decision support for chemotherapy‐induced neutropenia using a hybrid pharmacodynamic/machine learning model por Jasmine H. Hughes, Dominic Tong, Vanessa Burns, Bobby Daly, Pedram Razavi, Jaap Jan Boelens, Srijib Goswami, Ron J. Keizer
Publicado 2023Artigo -
6
-
7
-
8
Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi‐row detector computed tomography scanning por Casey L. O’Connell, Pedram Razavi, Mohammad Ghalichi, S. Boyle, S. VASAN, Lisa Mark, Amy Caton, Vinay Duddalwar, William D. Boswell, Kristen Grabow, Howard A. Liebman
Publicado 2010Artigo -
9
Shift Work, Chronotype, and Melatonin Rhythm in Nurses por Pedram Razavi, Elizabeth E. Devore, Archna Bajaj, Steven W. Lockley, Mariana G. Figueiro, Vincent Ricchiuti, W. James Gauderman, Susan E. Hankinson, Walter C. Willett, Eva Schernhammer
Publicado 2019Artigo -
10
Associations between Polymorphisms in DNA Repair Genes and Glioblastoma por Roberta McKean‐Cowdin, Jill S. Barnholtz‐Sloan, Peter D. Inskip, Avima M. Ruder, M. A. Butler, Preetha Rajaraman, Pedram Razavi, Joe Patoka, John K. Wiencke, Melissa L. Bondy, Margaret Wrensch
Publicado 2009Artigo -
11
Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer por Sung Soo Kim, Jessica Armand, Anton Safonov, Mimi Zhang, Rajesh K. Soni, Gary K. Schwartz, Julia E. McGuinness, Hanina Hibshoosh, Pedram Razavi, Minah Kim, Sarat Chandarlapaty, Hee Won Yang
Publicado 2023Artigo -
12
PDK1-SGK1 Signaling Sustains AKT-Independent mTORC1 Activation and Confers Resistance to PI3Kα Inhibition por Pau Castel, Haley Ellis, Ružica Bago, Eneda Toska, Pedram Razavi, F. Javier Carmona, Srinivasaraghavan Kannan, Chandra Verma, Maura N. Dickler, Sarat Chandarlapaty, Edi Brogi, Dario R. Alessi, José Baselga, Maurizio Scaltriti
Publicado 2016Artigo -
13
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status por Dara S. Ross, Ahmet Zehir, Donavan T. Cheng, Ryma Benayed, Khédoudja Nafa, Jaclyn F. Hechtman, Yelena Y. Janjigian, Britta Weigelt, Pedram Razavi, David M. Hyman, José Baselga, Michael F. Berger, Marc Ladanyi, Maria E. Arcila
Publicado 2016Artigo -
14
KMT2C mediates the estrogen dependence of breast cancer through regulation of ERα enhancer function por Kinisha Gala, Qing Li, Amit Sinha, Pedram Razavi, M. Dorso, Francisco Sánchez-Vega, Young Rock Chung, Ronald C. Hendrickson, James J. Hsieh, Michael F. Berger, Nikolaus Schultz, Alessandro Pastore, Omar Abdel‐Wahab, Sarat Chandarlapaty
Publicado 2018Artigo -
15
Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Failure in ER+ Metastatic Breast Cancer por Komal Jhaveri, Nicholas Mai, Carlos Henrique dos Anjos, Pedram Razavi, Anton Safonov, Sujata Patil, Yuan Chen, Joshua Z. Drago, Shanu Modi, Jacqueline Bromberg, Chau T. Dang, Dazhi Liu, Larry Norton, Mark E. Robson, Sarat Chandarlapaty
Publicado 2024Pré-impressão -
16
Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer por Nicholas Mai, Carlos Henrique dos Anjos, Pedram Razavi, Anton Safonov, Sujata Patil, Yuan Chen, Joshua Z. Drago, Shanu Modi, Jacqueline Bromberg, Chau T. Dang, Dazhi Liu, Larry Norton, Mark E. Robson, Sarat Chandarlapaty, Komal Jhaveri
Publicado 2024Artigo -
17
HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway por Alison Smith, Emanuela Ferraro, Anton Safonov, Cristina Bernadó Morales, Enrique J. Arenas, Qing Li, Amanda Kulick, Dara S. Ross, David B. Solit, Elisa de Stanchina, Jorge S. Reis‐Filho, Neal Rosen, Joaquı́n Arribas, Pedram Razavi, Sarat Chandarlapaty
Publicado 2021Artigo -
18
A machine learning model that classifies breast cancer pathologic complete response on MRI post-neoadjuvant chemotherapy por Elizabeth J. Sutton, Natsuko Onishi, Duc Fehr, Brittany Z. Dashevsky, Meredith Sadinski, Katja Pinker, Danny F. Martinez, Edi Brogi, Lior Z. Braunstein, Pedram Razavi, Mahmoud El‐Tamer, Virgilio Sacchini, Joseph O. Deasy, Elizabeth A. Morris, Harini Veeraraghavan
Publicado 2020Artigo -
19
Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis por Anna Skakodub, Henry Walch, Kathryn R. Tringale, Jordan Eichholz, Brandon S. Imber, Harish N. Vasudevan, Bob T. Li, Nelson S. Moss, Kenny Yu, Boris Mueller, Simon N. Powell, Pedram Razavi, Helena A. Yu, Jorge S. Reis‐Filho, Daniel R. Gomez, Nikolaus Schultz, Luke Pike
Publicado 2023Artigo -
20
The genomic landscape of metastatic histologic special types of invasive breast cancer por Fresia Pareja, Lorenzo Ferrando, Simon S. K. Lee, Francisco Beça, Pier Selenica, David Brown, Amir Farmanbar, Arnaud Da Cruz Paula, Mahsa Vahdatinia, Hong Zhang, Gabriele Zoppoli, Hannah Y. Wen, Edi Brogi, Mark E. Robson, Pedram Razavi, Sarat Chandarlapaty, Britta Weigelt, Jorge S. Reis‐Filho
Publicado 2020Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Cancer
Medicine
Internal medicine
Cancer research
Breast cancer
Genetics
Oncology
Gene
Mutation
Bioinformatics
Pathology
Computational biology
Cell biology
Confidence interval
Estrogen receptor
Kinase
Estrogen
Estrogen receptor alpha
PI3K/AKT/mTOR pathway
Signal transduction
Somatic cell
Lung cancer
Metastatic breast cancer
Paleontology
Physics
Allele
Biochemistry
Cell cycle
Cell-free fetal DNA